Now showing items 1-2 of 2

    • Neurosarcoidosis following Immune Checkpoint Inhibition. 

      Dunn-Pirio, Anastasie M; Shah, Suma; Eckstein, Christopher (Case reports in oncology, 2018-05)
      Recently, immune checkpoint inhibitors have revolutionized cancer care by enhancing anti-tumor immunity. However, by virtue of stimulating the immune system, they can lead to immune-related adverse events (irAEs). Neurologic ...
    • Nivolumab-Induced Autoimmune Encephalitis in Two Patients with Lung Adenocarcinoma. 

      Shah, Suma; Dunn-Pirio, Anastasie; Luedke, Matthew; Morgenlander, Joel; Skeen, Mark; Eckstein, Christopher (Case reports in neurological medicine, 2018-01)
      Immune checkpoint inhibitors have improved patient survival outcomes in a variety of advanced malignancies. However, they can cause a number of immune-related adverse effects (irAEs) through lymphocyte dysregulation. Central ...